6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate

C76H74BF3N8O11S2 — CID 174144754

IUPAC6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate
SMILESCC(C)(C)OC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)ccc1B1OC(C)(C)C(C)(C)O1.CCOC(=O)CC[C@@H](c1ccc(Oc2cccc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)cc1)C(F)(F)F
InChIInChI=1S/C43H37F3N4O6S.C33H37BN4O5S/c1-3-55-38(51)21-19-33(43(44,45)46)27-14-16-28(17-15-27)56-35-12-7-9-29(25(35)2)30-18-20-37(48-39(30)41(53)54)50-23-22-26-8-6-10-31(32(26)24-50)40(52)49-42-47-34-11-4-5-13-36(34)57-42;1-31(2,3)41-29(40)27-23(34-42-32(4,5)33(6,7)43-34)15-16-26(36-27)38-18-17-20-11-10-12-21(22(20)19-38)28(39)37-30-35-24-13-8-9-14-25(24)44-30/h4-18,20,33H,3,19,21-24H2,1-2H3,(H,53,54)(H,47,49,52);8-16H,17-19H2,1-7H3,(H,35,37,39)/t33-;/m0./s1
InChIKeyXJWNGOXHIWJEOR-WAQYZQTGSA-N
MW1407.41 g/mol
LogP15.72
Rot. Bonds17

About 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate

6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate (PubChem CID 174144754) has the molecular formula C76H74BF3N8O11S2 and a molecular weight of 1407.41 g/mol. Its IUPAC name is 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate.

Molecular Properties

Compound Name6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate
PubChem CID174144754
Molecular FormulaC76H74BF3N8O11S2
Molecular Weight1407.41 g/mol
Exact Mass1406.50
IUPAC Name6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate
SMILESCC(C)(C)OC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)ccc1B1OC(C)(C)C(C)(C)O1.CCOC(=O)CC[C@@H](c1ccc(Oc2cccc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)cc1)C(F)(F)F
InChIInChI=1S/C43H37F3N4O6S.C33H37BN4O5S/c1-3-55-38(51)21-19-33(43(44,45)46)27-14-16-28(17-15-27)56-35-12-7-9-29(25(35)2)30-18-20-37(48-39(30)41(53)54)50-23-22-26-8-6-10-31(32(26)24-50)40(52)49-42-47-34-11-4-5-13-36(34)57-42;1-31(2,3)41-29(40)27-23(34-42-32(4,5)33(6,7)43-34)15-16-26(36-27)38-18-17-20-11-10-12-21(22(20)19-38)28(39)37-30-35-24-13-8-9-14-25(24)44-30/h4-18,20,33H,3,19,21-24H2,1-2H3,(H,53,54)(H,47,49,52);8-16H,17-19H2,1-7H3,(H,35,37,39)/t33-;/m0./s1
InChIKeyXJWNGOXHIWJEOR-WAQYZQTGSA-N
XLogP15.72
TPSA233.83 Ų
H-Bond Donors3
H-Bond Acceptors18
Rotatable Bonds17
Heavy Atoms101
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001407.41
LogP ≤ 515.72
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate?
The IUPAC name of 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate (CID 174144754) is 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate.
What is the SMILES notation for 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate?
The canonical SMILES for 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate is CC(C)(C)OC(=O)c1nc(N2CCc3cccc(C(=O)Nc4nc5ccccc5s4)c3C2)ccc1B1OC(C)(C)C(C)(C)O1.CCOC(=O)CC[C@@H](c1ccc(Oc2cccc(-c3ccc(N4CCc5cccc(C(=O)Nc6nc7ccccc7s6)c5C4)nc3C(=O)O)c2C)cc1)C(F)(F)F.
What is the InChIKey of 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate?
The InChIKey is XJWNGOXHIWJEOR-WAQYZQTGSA-N. The full InChI is InChI=1S/C43H37F3N4O6S.C33H37BN4O5S/c1-3-55-38(51)21-19-33(43(44,45)46)27-14-16-28(17-15-27)56-35-12-7-9-29(25(35)2)30-18-20-37(48-39(30)41(53)54)50-23-22-26-8-6-10-31(32(26)24-50)40(52)49-42-47-34-11-4-5-13-36(34)57-42;1-31(2,3)41-29(40)27-23(34-42-32(4,5)33(6,7)43-34)15-16-26(36-27)38-18-17-20-11-10-12-21(22(20)19-38)28(39)37-30-35-24-13-8-9-14-25(24)44-30/h4-18,20,33H,3,19,21-24H2,1-2H3,(H,53,54)(H,47,49,52);8-16H,17-19H2,1-7H3,(H,35,37,39)/t33-;/m0./s1.
What are the key properties of 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate?
6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate has a molecular weight of 1407.41 g/mol, XLogP of 15.72, 17 rotatable bonds, 3 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-[3-[4-[(2S)-5-ethoxy-1,1,1-trifluoro-5-oxopentan-2-yl]phenoxy]-2-methylphenyl]pyridine-2-carboxylic acid;tert-butyl 6-[8-(1,3-benzothiazol-2-ylcarbamoyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine-2-carboxylate is sourced from PubChem (CID 174144754), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).